Evidence map›Paper›PMID 38929734›Full record

ReviewLife (Basel, Switzerland)2024

A Review of Advances in Molecular Imaging of Rheumatoid Arthritis: From In Vitro to Clinic Applications Using Radiolabeled Targeting Vectors with Technetium-99m.

Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, Riccardo Laudicella, Antonino Tuttolomondo, Albert Comelli

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad AliRi.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.ORCID 0000-0001-7913-704X
Viviana BenfanteRi.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.ORCID 0000-0002-3629-355X
Domenico Di RaimondoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Molecular and Clinical Medicine, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-4529-3703
Riccardo LaudicellaNuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Messina University, 98124 Messina, Italy.
Antonino TuttolomondoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Molecular and Clinical Medicine, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0001-6440-7318
Albert ComelliRi.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.ORCID 0000-0002-9290-6103

Funding

National Center 5 "National Biodiversity Future Center", theme "Bio-diversità", in the frame-work of the Piano Nazionale di Ripresa e resilienza, Mission 4 Component 2 Investment 1.4, funded by the European Union-NextGenerationEU, identification code CN00 CN00000033, CUP B73C21001300006
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disorder caused by inflammation of cartilaginous diarthrodial joints that destroys joints and cartilage, resulting in synovitis and pannus formation. Timely detection and effective management of RA are pivotal for mitigating inflammatory arthritis consequences, potentially influencing disease progression. Nuclear medicine using radiolabeled targeted vectors presents a promising avenue for RA diagnosis and response to treatment assessment. Radiopharmaceutical such as technetium-99m (

Indexed as

99mTcautoimmune disordercomputed tomographynuclear medicineRAradiopharmaceuticalsscintigraphysingle-photon emission computed tomographySPECT/CTsynovitis

Identifiers

PMID38929734
PMCPMC11204982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.